High Net Worth Advisory Group LLC Belite Bio, Inc Transaction History
High Net Worth Advisory Group LLC
- $388 Million
- Q3 2025
A detailed history of High Net Worth Advisory Group LLC transactions in Belite Bio, Inc stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 3,500 shares of BLTE stock, worth $322,000. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,500Holding current value
$322,000% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding BLTE
# of Institutions
19Shares Held
79.9KCall Options Held
0Put Options Held
0-
State Street Corp Boston, MA20.2KShares$1.86 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12.9KShares$1.18 Million0.0% of portfolio
-
Marshall Wace, LLP London, X09.49KShares$872,7120.0% of portfolio
-
Jpmorgan Chase & CO New York, NY8.16KShares$750,9040.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.46KShares$685,9520.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $2.29B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...